Načítá se...
Extended Mortality Results for Prostate Cancer Screening in the PLCO Trial with Median 15 Years Follow-up
BACKGROUND: Two large-scale prostate cancer screening trials with prostate-specific antigen (PSA) have given conflicting results in terms of the efficacy of such screening. One of those trials, the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, previously reported outcomes thr...
Uloženo v:
| Vydáno v: | Cancer |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5725951/ https://ncbi.nlm.nih.gov/pubmed/27911486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30474 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|